Literature DB >> 32510549

DenvInD: dengue virus inhibitors database for clinical and molecular research.

Vivek Dhar Dwivedi, Aditya Arya, Pardeep Yadav, Rajesh Kumar, Vinod Kumar, Gajendra P S Raghava.   

Abstract

Dengue virus (DENV) researchers often face challenges with the highly time-consuming process of collecting and curating information on known inhibitors during the standard drug discovery process. To this end, however, required collective information is not yet available on a single platform. Hence, we have developed the DenvInD database for experimentally validated DENV inhibitors against its known targets presently hosted at https://webs.iiitd.edu.in/raghava/denvind/. This database provides comprehensive information, i.e. PubChem IDs, SMILES, IC50, EC50, CC50, and wherever available Ki values of the 484 compounds in vitro validated as inhibitors against respective drug targets of DENV. Also, the DenvInD database has been linked to the user-friendly web-based interface and accessibility features, such as simple search, advanced search and data browsing. All the required data curation was conducted manually from the reported scientific literature and PubChem. The collected information was then organized into the DenvInD database using sequence query language under user interface by hypertext markup language. DenvInD is the first useful repository of its kind which would augment the DENV drug discovery research by providing essential information on known DENV inhibitors for molecular docking, computational screening, pharmacophore modeling and quantitative structure-activity relationship modeling.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Dengue virus; database; inhibitor; methyltransferase; polymerase; protease

Year:  2021        PMID: 32510549     DOI: 10.1093/bib/bbaa098

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  2 in total

Review 1.  Dengue virus NS4B protein as a target for developing antivirals.

Authors:  Qingxin Li; Congbao Kang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-09       Impact factor: 6.073

2.  Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase.

Authors:  Sanjay Kumar; Leena H Bajrai; Arwa A Faizo; Aiah M Khateb; Areej A Alkhaldy; Rashmi Rana; Esam I Azhar; Vivek Dhar Dwivedi
Journal:  Viruses       Date:  2022-08-20       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.